| Trial ID: | L3920 |
| Source ID: | NCT03766750
|
| Associated Drug: |
Lima Association
|
| Title: |
Efficacy and Safety of Lima Association in the Control of Type II Diabetes Mellitus.
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type2 Diabetes Mellitus
|
| Interventions: |
DRUG: LIMA association|DRUG: Tradjenta|DRUG: Forxiga
|
| Outcome Measures: |
Primary: Reduction of glycated hemoglobin levels measured between the first visit and the last visit., 120 days | Secondary: Incidence and severity of adverse events recorded during the study., 210 days
|
| Sponsor/Collaborators: |
Sponsor: EMS
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2021-12
|
| Completion Date: |
2023-11
|
| Results First Posted: |
|
| Last Update Posted: |
2022-07-27
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT03766750
|
